| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a376514db34209e4b9c77363cc87c1b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb7cdd4eeab86567e4ce4cb263c7f4f0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-12122 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-175 |
| filingDate |
1997-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54b4a52d4bb6a225c54274019e494c5f |
| publicationDate |
1997-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9728819-A1 |
| titleOfInvention |
Vaccine against hantavirus |
| abstract |
Virus vaccine against Hantaviruses, especially Puumala virus, which comprises, an immunizing component, at least one member of the group consisting of: a) a recombinant protein having the amino-acid sequence of the figure; b) fragments of said protein which comprise B-cell and/or T-cell epitopes; and c) amino-acid sequences which are at least 80 % homologous to the sequences of a) or b) and which comprise B-cell and/or T-cell epitopes, are disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11286299-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02053183-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11198715-B2 |
| priorityDate |
1996-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |